Elite in Teratocarcinosarcoma

Kumar Prabhash

Mumbai, MH, IN 
Elite in Teratocarcinosarcoma
Mumbai, MH, IN 
OverviewLocationsClinical Research

Overview

Kumar Prabhash practices in Mumbai, India. Mr. Prabhash is rated as an Elite expert by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tissue Biopsy, and Cystectomy.

His clinical research consists of co-authoring 532 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Teratocarcinosarcoma.

Gender
Male

Locations

Mumbai, MH, India
Other Locations
Parel, JK, India
Navi Mumbai, MH, India
Bhabha, MP, India
Parel, MH, India
Department Of Head And Neck Oncology, Tata, UP, India
Bengaluru, KA, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effect of COX-2 (Cyclooxygenase-2) and EGFR (Epidermal Growth Factor Receptor) Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study.
Effect of COX-2 (Cyclooxygenase-2) and EGFR (Epidermal Growth Factor Receptor) Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study.
Enrollment Status: Unknown
Publish Date: April 28, 2022
Intervention Type: Drug, Other
Study Drugs: Celecoxib, Erlotinib
Study Phase: Phase 2
A Randomized Study of the Safety and Efficacy of BIO-11006 in Treatment of Advanced Non-Small Cell Lung Cancer in Patients Who Are Not Candidates for Curative Surgery and/or Radiation and Who Are Receiving Pemetrexed and Carboplatin
A Randomized Study of the Safety and Efficacy of BIO-11006 in Treatment of Advanced Non-Small Cell Lung Cancer in Patients Who Are Not Candidates for Curative Surgery and/or Radiation and Who Are Receiving Pemetrexed and Carboplatin
Enrollment Status: Completed
Publish Date: May 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

532 Total Publications

Response to Letter Re: "A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer".
Response to Letter Re: "A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer".
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Prabhash's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 77 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile